Dexcom +5% as FDA approves pediatric use of glucose monitoring system

|By:, SA News Editor

DexCom (DXCM+5.1% AH after the FDA approves pediatric use of the company’s G4 Platinum continuous glucose monitoring system.

The G4 Platinum System, which monitors blood glucose levels in people with diabetes, already had been approved for patients age 18 and older.